96-11012. Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning A Vaccine Against Gram- Negative Bacterial Infections  

  • [Federal Register Volume 61, Number 87 (Friday, May 3, 1996)]
    [Notices]
    [Page 19910]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-11012]
    
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF DEFENSE
    Department of the Army
    
    
    Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
    Licensing of U.S. Patent Application Concerning A Vaccine Against Gram-
    Negative Bacterial Infections
    
    AGENCY: U.S. Army Medical Research and Materiel Command, DOD.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
    availability for licensing of U.S. Patent Application Serial No. 08/
    230,402 entitled ``Vaccine Against Gram-Negative Bacterial Infections'' 
    and 20 April, 1994 and Foreign Patent Application PCT/US95/04446 filed 
    April 20, 1995. This patent has been assigned to the United States 
    Government as represented by the Secretary of the Army.
    
    ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
    ATTN: Staff Judge Advocate, Fort Detrick, Frederick, Maryland 21702-
    5012.
    
    FOR FURTHER INFORMATION CONTACT: Mr. John F. Moran, Patent Attorney, 
    (301) 619-2065 or telefax (301) 619-7714.
    
    SUPPLEMENTARY INFORMATION: The invention relates to a vaccine which is 
    effective in inducing the production of antibodies with which to 
    immunize a second subject passively against infection by Gram-negative 
    bacteria and LPS-mediated pathology. The vaccine comprises a non-
    covalent polyvalent complex formed between purified, detoxified LPS 
    derived from E. coli and purified outer membrane protein derived from 
    N. meningitidis. The same vaccine will also actively immunize a host 
    subject against Gram-negative bacterial infections and LPS-mediated 
    pathology. Meningococcal infections are included among those Gram-
    negative bacterial infections protected against by the vaccine.
    Gregory D. Showalter,
    Army Federal Register Liaison Officer.
    [FR Doc. 96-11012 Filed 5-2-96; 8:45 am]
    BILLING CODE 3710-08-M
    
    

Document Information

Published:
05/03/1996
Department:
Army Department
Entry Type:
Notice
Action:
Notice.
Document Number:
96-11012
Pages:
19910-19910 (1 pages)
PDF File:
96-11012.pdf